130 related articles for article (PubMed ID: 36603162)
1. A new series of hydrazones as small-molecule aldose reductase inhibitors.
Altıntop MD; Demir Y; Türkeş C; Öztürk RB; Cantürk Z; Beydemir Ş; Özdemir A
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200570. PubMed ID: 36603162
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors.
Demir Y; Tokalı FS; Kalay E; Türkeş C; Tokalı P; Aslan ON; Şendil K; Beydemir Ş
Mol Divers; 2023 Aug; 27(4):1713-1733. PubMed ID: 36103032
[TBL] [Abstract][Full Text] [Related]
3. Biological effects of bis-hydrazone compounds bearing isovanillin moiety on the aldose reductase.
Yapar G; Esra Duran H; Lolak N; Akocak S; Türkeş C; Durgun M; Işık M; Beydemir Ş
Bioorg Chem; 2021 Dec; 117():105473. PubMed ID: 34768205
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines.
Sever B; Altıntop MD; Demir Y; Yılmaz N; Akalın Çiftçi G; Beydemir Ş; Özdemir A
Chem Biol Interact; 2021 Aug; 345():109576. PubMed ID: 34252406
[TBL] [Abstract][Full Text] [Related]
6. Novel acetic acid derivatives containing quinazolin-4(3H)-one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors.
Tokalı FS; Demir Y; Türkeş C; Dinçer B; Beydemir Ş
Drug Dev Res; 2023 Apr; 84(2):275-295. PubMed ID: 36598092
[TBL] [Abstract][Full Text] [Related]
7. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
Celestina SK; Sundaram K; Ravi S
Bioorg Chem; 2020 Apr; 97():103640. PubMed ID: 32086051
[TBL] [Abstract][Full Text] [Related]
8. Determination of the inhibition profiles of pyrazolyl-thiazole derivatives against aldose reductase and α-glycosidase and molecular docking studies.
Demir Y; Taslimi P; Koçyiğit ÜM; Akkuş M; Özaslan MS; Duran HE; Budak Y; Tüzün B; Gürdere MB; Ceylan M; Taysi S; Gülçin İ; Beydemir Ş
Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000118. PubMed ID: 32761859
[TBL] [Abstract][Full Text] [Related]
9. Screening inhibitory effects of selected flavonoids on human recombinant aldose reductase enzyme:
Comakli V; Adem S; Oztekin A; Demirdag R
Arch Physiol Biochem; 2022 Oct; 128(5):1368-1374. PubMed ID: 32463711
[TBL] [Abstract][Full Text] [Related]
10. N-substituted phthalazine sulfonamide derivatives as non-classical aldose reductase inhibitors.
Türkeş C; Arslan M; Demir Y; Çoçaj L; Nixha AR; Beydemir Ş
J Mol Recognit; 2022 Dec; 35(12):e2991. PubMed ID: 36073557
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and aldose reductase inhibition effects of celecoxib derivatives containing pyrazole linked-sulfonamide moiety.
Bayrak C
Bioorg Chem; 2022 Nov; 128():106086. PubMed ID: 35973306
[TBL] [Abstract][Full Text] [Related]
12. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
13. Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors.
Hussain S; Parveen S; Qin X; Hao X; Zhang S; Chen X; Zhu C; Ma B
Bioorg Med Chem Lett; 2014 May; 24(9):2086-9. PubMed ID: 24726808
[TBL] [Abstract][Full Text] [Related]
14. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
Reddy TN; Ravinder M; Bagul P; Ravikanti K; Bagul C; Nanubolu JB; Srinivas K; Banerjee SK; Rao VJ
Eur J Med Chem; 2014 Jan; 71():53-66. PubMed ID: 24275248
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and activity of a new series of (Z)-3-phenyl-2-benzoylpropenoic acid derivatives as aldose reductase inhibitors.
Wang SJ; Yan JF; Hao D; Niu XW; Cheng MS
Molecules; 2007 Apr; 12(4):885-95. PubMed ID: 17851441
[TBL] [Abstract][Full Text] [Related]
17. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
Kucerova-Chlupacova M; Halakova D; Majekova M; Treml J; Stefek M; Soltesova Prnova M
Chem Biol Interact; 2020 Dec; 332():109286. PubMed ID: 33038328
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors.
Wu B; Yang Y; Qin X; Zhang S; Jing C; Zhu C; Ma B
ChemMedChem; 2013 Dec; 8(12):1913-7. PubMed ID: 24115741
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel quinazolin-4(1H)-one derivatives as potent and selective inhibitors targeting AKR1B1.
Han Z; Li J; Xu Z; Su Y; Wang Y; Zhuo L; Du J; Zhu C; Hao X
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200577. PubMed ID: 36707406
[TBL] [Abstract][Full Text] [Related]
20. Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation.
Imran A; Tariq Shehzad M; Al Adhami T; Miraz Rahman K; Hussain D; Alharthy RD; Shafiq Z; Iqbal J
Bioorg Chem; 2021 Oct; 115():105164. PubMed ID: 34314916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
